BACKGROUND: Limited survival data are available on chronic kidney disease stage 5 (CKD 5) patients who opt for conservative management rather than dialysis. AIM: To measure survival in such patients and investigate potential factors predicting survival. DESIGN: Retrospective survival analysis of a cohort of conservatively managed CKD 5 patients from a single center. METHODS: Survival was measured in 69 conservatively managed patients from the time they were first known to have CKD 5. Comorbidities, residual renal function and other laboratory parameters (calcium, phosphate, parathyroid hormone, albumin and hemoglobin) and blood pressure were recorded. RESULTS: Overall median patient survival from the time of first known CKD 5 was 21 months. Patients known to a nephrologist before reaching CKD 5 survived longer (median 32 months) than those presenting with CKD 5 (15 months, P = 0.025). Serum albumin >35 g/l was associated with greater survival, but other biochemical parameters, comorbidity grade and age did not predict survival. CONCLUSION: These survival data provide useful information for nephrologists counseling CKD 5 patients considering whether to pursue dialysis or conservative management. Risk factors that correlate with survival in the dialysis population may not predict survival in conservatively managed CKD 5 patients.
BACKGROUND: Limited survival data are available on chronic kidney disease stage 5 (CKD 5) patients who opt for conservative management rather than dialysis. AIM: To measure survival in such patients and investigate potential factors predicting survival. DESIGN: Retrospective survival analysis of a cohort of conservatively managed CKD 5 patients from a single center. METHODS: Survival was measured in 69 conservatively managed patients from the time they were first known to have CKD 5. Comorbidities, residual renal function and other laboratory parameters (calcium, phosphate, parathyroid hormone, albumin and hemoglobin) and blood pressure were recorded. RESULTS: Overall median patient survival from the time of first known CKD 5 was 21 months. Patients known to a nephrologist before reaching CKD 5 survived longer (median 32 months) than those presenting with CKD 5 (15 months, P = 0.025). Serum albumin >35 g/l was associated with greater survival, but other biochemical parameters, comorbidity grade and age did not predict survival. CONCLUSION: These survival data provide useful information for nephrologists counseling CKD 5 patients considering whether to pursue dialysis or conservative management. Risk factors that correlate with survival in the dialysis population may not predict survival in conservatively managed CKD 5 patients.
Authors: Rachael L Morton; Paul Snelling; Angela C Webster; John Rose; Rosemary Masterson; David W Johnson; Kirsten Howard Journal: CMAJ Date: 2012-02-06 Impact factor: 8.262
Authors: Wouter R Verberne; A B M Tom Geers; Wilbert T Jellema; Hieronymus H Vincent; Johannes J M van Delden; Willem Jan W Bos Journal: Clin J Am Soc Nephrol Date: 2016-03-17 Impact factor: 8.237
Authors: Mae Thamer; James S Kaufman; Yi Zhang; Qian Zhang; Dennis J Cotter; Heejung Bang Journal: Am J Kidney Dis Date: 2015-06-26 Impact factor: 8.860
Authors: Susan P Y Wong; Margaret K Yu; Pamela K Green; Chuan-Fen Liu; Paul L Hebert; Ann M O'Hare Journal: Am J Kidney Dis Date: 2018-01-10 Impact factor: 8.860
Authors: Fliss E M Murtagh; Aine Burns; Olivier Moranne; Rachael L Morton; Saraladevi Naicker Journal: Clin J Am Soc Nephrol Date: 2016-08-10 Impact factor: 8.237
Authors: Mario Pacilio; Roberto Minutolo; Carlo Garofalo; Maria Elena Liberti; Giuseppe Conte; Luca De Nicola Journal: J Nephrol Date: 2015-11-19 Impact factor: 3.902